Clinical Trial Update: Efficacy of Treatment With Berberine to Maintain Remission in Ulcerative Colitis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating berberine to maintain remission in ulcerative colitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Berberine (berberine)

Snippet

Sponsor: Xijing Hospital of Digestive Diseases | Conditions: Ulcerative Colitis | Phase 4 | Status: WITHDRAWN